Veterinary Medicines

Neomycinesulfaat, poeder voor toediening via drinkwater

Authorised
  • NEOMYCIN SULFATE
Download as PDF

Product identification

Medicine name:
Neomycinesulfaat, poeder voor toediening via drinkwater
Active substance:
  • NEOMYCIN SULFATE
Target species:
  • Cattle (calf)
  • Pig
  • Turkey
  • Chicken (chick)
Route of administration:
  • In drinking water/milk use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    1000.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water/milk
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Cattle (calf)
      • Meat and offal
        21
        day
    • Pig
      • Meat and offal
        21
        day
    • Turkey
      • Meat and offal
        7
        day
    • Chicken (chick)
      • Meat and offal
        7
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Eurovet Animal Health B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 7276
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 23/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."